Abstract
We studied sterility and toxicity of vaccine LS1 containing aberrant gangliosides isolated from brain bioptates of 48 patients with gliomas of different malignancy and covalently bound to keyhole limpet hemocyanin. The vaccine was safe. This preparation produced no side effects in experimental animals. Our findings substantiated the necessity of father development of this method of vaccination. The vaccine should undergo clinical tests in patients with malignant gliomas.
Similar content being viewed by others
REFERENCES
S. Ando and R. K. Yu, J. Biol. Chem., 254, 12,224–12,229 (1979).
F. G. H. Barker, R. L. Davis, S. M. Chang, and M. D. Pardos, Cancer, 77, 1161–1166 (1996).
J. M. Bruker, Grading by WHO Classification of Primary Brain Tumors, Ed. W. S. Fields, London (1989).
B. C. Devaux, J. R. O'Fallon, and P. J. Kelly, J. Neurosurg., 78, 767–775 (1993).
S. Hakomori, Ann. Rev. Biochem., 50, 733–743 (1981).
F. Helling and P. O. Livingston, Mol. Chem. Neuropathol., 21, 299–309 (1994).
F. Helling, A. Shang, M. Calves, et al., Cancer Res., 54, 197–203 (1994).
P. O. Livingston, M. J. Calves, F. Helling, et al., Vaccine, 11, 1199–1204 (1993).
J. L. Hintze, Power Analysis and Sample Size for Windows: PASS 6.0 (User's Guide), Kaysville (1996), pp. 179–184.
F. W. Kreth, P. C. Warnke, R. Scherement, and C. B. Ostertag, J. Neurosurg., 78, 762–766 (1993).
V. Lombardi, Eur. J. Neurol., 4,Suppl. 1, 233 (1997).
V. Lombardi, Exp. Oncol., 22,Suppl. 2, 43–45 (2000).
V. Lombardi, M. Valko, A. Scozzafava, et al., Cell. Mol. Neurobiol., 17, 521–535 (1997).
R. L. Schnaar, S. E. Fromholt, Y. Gong, et al., Anal. Biochem., 302, 276–284 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lombardi, V., Shnaar, R., Minev, B. et al. Conjugates of Aberrant Gangliosides in Antiglioma Vaccine: Toxicological Assay. Bulletin of Experimental Biology and Medicine 134, 363–365 (2002). https://doi.org/10.1023/A:1021908331236
Issue Date:
DOI: https://doi.org/10.1023/A:1021908331236